BioCircuit Technologies
PrivateLast Round
Grant
Nov 20, 2024
Total Funding Raised
$21.06M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BioCircuit Technologies is a medical device company that develops and commercializes advanced solutions for tissue repair and neuromodulation, including its flagship sutureless nerve repair product, Nerve Tape®.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioCircuit Technologies Comparables
Compare BioCircuit Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuraptive Therapeutics | 89% | |
| Tissium | 86% | |
| Swan NeuroTech | 84% |
BioCircuit Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 20, 2024 | ||||
| Grant | Oct 19, 2023 | ||||
| Seed | Sep 27, 2022 | ||||
| Grant | May 4, 2021 | ||||
| Seed | Apr 22, 2021 |
BioCircuit Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Georgia Research Alliance | Seed |
| Masters Capital Management | Seed |
| Alsora Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 56% MoM.
- Sep 10, 2025
Launched the ConformaWrap nerve protector.
Recent news
Latest coverage and updates
- spins_off_divisionSep 10, 2026
BioCircuit Technologies spun off electronics research and development business on Jul 1st '26.
BioCircuit Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioCircuit Technologies's valuation, stock price, and market status.
Is BioCircuit Technologies a public or private company?
BioCircuit Technologies is a private company.
What is the current stock price of BioCircuit Technologies?
BioCircuit Technologies is a private company with no public stock price. No recent secondary market data is available.
How much is BioCircuit Technologies worth (valuation)?
Valuation information for BioCircuit Technologies is not publicly available.
Can I buy BioCircuit Technologies stock?
BioCircuit Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioCircuit Technologies's last funding round?
BioCircuit Technologies's most recent funding round was Grant on November 20, 2024.
Who are the main investors in BioCircuit Technologies?
Key investors in BioCircuit Technologies include NIH RADx, Masters Capital Management.
Will BioCircuit Technologies IPO soon?
No public IPO plans have been announced for BioCircuit Technologies.
How can I track BioCircuit Technologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioCircuit Technologies's secondary market activity and sign up for updates.